Sanofi (SNW2) — Capital Reinvestment Ratio
Latest as of December 2024:
0.35x
Sanofi (SNW2) has a Capital Reinvestment Ratio of 0.35x as of December 2024, meaning it reinvests 0% of its operating cash flow (€9.08 Billion) in capital expenditures (€3.19 Billion). Check Sanofi tangible equity quality to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
0.35x
Capex / Operating Cash Flow
Operating Cash Flow
€9.08 Billion
EUR
Capital Expenditures
€3.19 Billion
EUR
Data as of
Dec 2024
Most recent filing
Sanofi Capital Reinvestment Ratio (2016–2024)
This chart tracks Sanofi's Capital Reinvestment Ratio across 9 annual periods. For the full cash flow conversion analysis, see Sanofi (SNW2) cash conversion ratio.
Annual Capital Reinvestment Ratio for Sanofi (2016–2024)
Year-by-year Capital Reinvestment Ratio for Sanofi from 2016 to 2024. See SNW2 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.35x | €9.08 Billion | €3.19 Billion | ▲ +19.3% |
| 2023 | 0.29x | €10.26 Billion | €3.02 Billion | ▲ +93.2% |
| 2022 | 0.15x | €10.53 Billion | €1.61 Billion | ▲ +8.5% |
| 2021 | 0.14x | €10.52 Billion | €1.48 Billion | ▼ -16.9% |
| 2020 | 0.17x | €7.42 Billion | €1.25 Billion | ▼ -1.4% |
| 2019 | 0.17x | €7.71 Billion | €1.32 Billion | ▼ -32.8% |
| 2018 | 0.26x | €5.55 Billion | €1.42 Billion | ▲ +35.6% |
| 2017 | 0.19x | €7.38 Billion | €1.39 Billion | ▼ -29.2% |
| 2016 | 0.27x | €7.84 Billion | €2.08 Billion | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow